Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Chen Chong Files Initial Ownership Statement With Ryde Group

Director Chen Chong filed a Form 3 initial statement of beneficial ownership with the SEC on November 13, 2026, disclosing holdings in Ryde Group Ltd (NYSE:RYDE) as of the same date.

Manish Choudhary | 13 November 2026

Nvidia Rebounds After Huang's Exit, Producer Prices Rise 0.3%, a Microsoft Outage Hits Shares, Cerebras Jumps 12% and Modine Surges 32%: 7 Reads Before Friday's Bell

1. NVIDIA: Shares Rebound 1.4% as the Senate Banking Chair Seeks Testimony From Huang and Commerce Secretary Lutnick

Nitish Kishor | 13 November 2026

AQR Capital Management Discloses 1.49% Teradata Stake

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended beneficial ownership statement with the SEC on November 13, 2026, reporting a combined holding of 1,389,276 shares of Teradata Corp common stock as of September 30, 2026.

Manish Choudhary | 13 November 2026

AQR Capital Management Reports 2.62% Stake in Repay Holdings

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed Amendment No. 2 to Schedule 13G with the SEC on November 13, 2026, disclosing their beneficial ownership position in Repay Holdings Corp as of September 30, 2026.

Shwetambri Chauhan | 13 November 2026

AQR Capital Holds 1,386,343 Sarepta Shares at 1.31%

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed Amendment No. 2 to Schedule 13G with the SEC on November 13, 2026, disclosing their beneficial ownership of common stock in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) as of September 30, 2026.

Vinay Lochav | 13 November 2026

AQR Capital Management Reports 4.98% Stake in Texas Capital Bancshares

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 2,164,817 shares of Texas Capital Bancshares Inc/TX common stock as of September 30, 2026.

Manish Choudhary | 13 November 2026

Crown Reserve SPAC Seeks Extension to February 2027 Deadline

Crown Reserve Acquisition Corp. I filed a preliminary proxy statement on November 13, 2026, seeking shareholder approval at an extraordinary general meeting scheduled for December 22, 2026, to extend its business combination deadline and ratify related proposals.

Aditi Sarkar | 13 November 2026

Xenetic Biosciences Reports Q3 2026 Results, Flags Santersus Deal

Xenetic Biosciences, Inc. filed a Current Report on Form 8-K on November 13, 2026, announcing third-quarter financial results for the three months ended September 30, 2026, and disclosing strategic business updates including a proposed share exchange transaction with Santersus AG.

Aditi Sarkar | 13 November 2026

Xenetic Biosciences Files 8-K for Q3 2026 Results and Santersus Deal Update

Xenetic Biosciences, Inc. filed a Current Report on Form 8-K on November 13, 2026, announcing third-quarter financial results for the period ended September 30, 2026, and providing strategic business updates including details related to a proposed share exchange transaction with Santersus AG.

Manish Choudhary | 13 November 2026

Tandem Mobi Receives FDA 510(k) Clearance for Tubeless AID

Tandem Diabetes Care, Inc. filed a Form 8-K on November 13, 2026, disclosing that it received 510(k) clearance from the U.S. Food and Drug Administration on November 12, 2026, for a tubeless configuration of its Tandem Mobi automated insulin delivery system.

Vinay Lochav | 13 November 2026
Support

Hi! How can we help you today?

Loading…